within Pharmacolibrary.Drugs.ATC.R;

model R03BC03
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 1e-06,
    adminDuration  = 600,
    adminMass      = 4 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R03BC03</td></tr><td>route:</td><td>inhalation</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Nedocromil is a mast cell stabilizer used primarily as an inhaled agent for the prophylactic treatment of asthma and allergic conjunctivitis. It inhibits the degranulation of mast cells, preventing the release of histamine and other mediators of inflammation. Its use has declined due to the introduction of more effective asthma therapies, but it was formerly approved in several countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adults after inhalation; limited published human PK data, values are largely based on secondary sources and estimation.</p><h4>References</h4><ol><li><p>Parish, RC, &amp; Miller, LJ (1993). Nedocromil sodium. <i>The Annals of pharmacotherapy</i> 27(5) 599–606. DOI:<a href=&quot;https://doi.org/10.1177/106002809302700515&quot;>10.1177/106002809302700515</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8394165/&quot;>https://pubmed.ncbi.nlm.nih.gov/8394165</a></p></li><li><p>Summers, QA, et al., &amp; Holgate, ST (1992). The effect of respiratory manoeuvres and pharmacological agents on the pharmacokinetics of nedocromil sodium after inhalation. <i>British journal of clinical pharmacology</i> 33(4) 431–438. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1992.tb04063.x&quot;>10.1111/j.1365-2125.1992.tb04063.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1315564/&quot;>https://pubmed.ncbi.nlm.nih.gov/1315564</a></p></li><li><p>Brogden, RN, &amp; Sorkin, EM (1993). Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma. <i>Drugs</i> 45(5) 693–715. DOI:<a href=&quot;https://doi.org/10.2165/00003495-199345050-00007&quot;>10.2165/00003495-199345050-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7686465/&quot;>https://pubmed.ncbi.nlm.nih.gov/7686465</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R03BC03;
